Article Information
History
- Received April 24, 2022
- Revision received July 13, 2022
- Revision received August 22, 2022
- Revision received October 5, 2022
- Revision received December 1, 2022
- Revision received December 2, 2022
- Accepted December 4, 2022
- Published online May 12, 2023.
Copyright & Usage
© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Lin Zhou, PhD,
- Zuotian Wu, MD,
- Dan Zhao, PhD,
- Gaohua Wang, MD,
- Ling Xiao, MD,
- Huiling Wang, MD,
- Yumeng Xie, MD,
- Limin Sun, MD
- From the Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China (Zhou, Wu, G. Wang, Xiao, H. Wang, Xie, Sun); the Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (Wu); the Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark (Zhao)
- Correspondence to: G. Wang, Institute of Neuropsychiatry, Renmin Hospital of Wuhan University, Jiefang Road No. 238, Wuhan 430060, China; wgh6402{at}whu.edu.cn